Skip to content
CancerIndex

Loading the knowledge graph…

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC — knowledge graph · CancerIndex